Literature DB >> 24112277

Involving patients in clinical research: the Telescot Patient Panel.

Peter Fairbrother1, Lucy McCloughan1, Geraldine Adam1, Richard Brand1, Cecil Brown1, Mary Watson1, Nicola Cotter2, Juliet Mackellaig2, Brian McKinstry1.   

Abstract

BACKGROUND: To date, patient involvement in the development of clinical research work has been limited. In 2011, the Telescot research team commenced work on a feasibility trial to investigate home telemonitoring of blood pressure for people who have experienced stroke or transient ischaemic attack (TIA). The team decided to involve patients in the development of the research.
OBJECTIVES: To improve research design through patient involvement. METHOD OF PATIENT INVOLVEMENT: A modified form of the 'Scrutiny Panel' approach was used to involve people who had stroke in the research project.
RESULTS: The Patient Panel supported the research in three key ways: it informed patient communication; it presented patient perspectives on the applicability and usability of the intervention; and it guided the development of the qualitative study. DISCUSSION: The initiative was considered a positive experience for all. However, challenges were identified in terms of the time and cost implications of undertaking patient involvement. IMPLICATION FOR RESEARCH PRACTICE: Importance is attached to adequate project planning and development, partnership working with community-based organizations and the necessity for clear role delineation between patients and professionals to enable effective collaborative working.
CONCLUSIONS: The Telescot Patient Panel was beneficial in supporting the development of the feasibility trial. The Panel approach was considered transferable to other clinical research contexts.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical trials; methodologies; patient involvement; primary care; stroke; telehealth

Mesh:

Year:  2013        PMID: 24112277      PMCID: PMC5055252          DOI: 10.1111/hex.12132

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  10 in total

1.  Assessment of the benefits of user involvement in health research from the Warwick Diabetes Care Research User Group: a qualitative case study.

Authors:  Antje Lindenmeyer; Hilary Hearnshaw; Jackie Sturt; Ralph Ormerod; Geoff Aitchison
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 3.  Benefits of and barriers to involving users in medical device technology development and evaluation.

Authors:  Syed Ghulam Sarwar Shah; Ian Robinson
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

4.  Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.

Authors:  Eni C Okonofua; Kit N Simpson; Ammar Jesri; Shakaib U Rehman; Valerie L Durkalski; Brent M Egan
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

Review 5.  Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.

Authors:  Peter M Rothwell; Ale Algra; Pierre Amarenco
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

6.  What patients want: consumer involvement in the design of a randomized controlled trial of routine oxygen supplementation after acute stroke.

Authors:  Khalid Ali; Christine Roffe; Peter Crome
Journal:  Stroke       Date:  2006-02-02       Impact factor: 7.914

7.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

8.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

9.  Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial.

Authors:  Liedeke Koops; Richard I Lindley
Journal:  BMJ       Date:  2002-08-24

10.  Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study.

Authors:  Hilary Pinnock; Marilyn Kendall; Scott A Murray; Allison Worth; Pamela Levack; Mike Porter; William MacNee; Aziz Sheikh
Journal:  BMJ       Date:  2011-01-24
  10 in total
  4 in total

1.  Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke/transient ischaemic attack (TIA).

Authors:  Janet Hanley; Peter Fairbrother; Ashma Krishan; Lucy McCloughan; Paul Padfield; Mary Paterson; Hilary Pinnock; Aziz Sheikh; Cathie Sudlow; Allison Todd; Brian McKinstry
Journal:  Trials       Date:  2015-03-25       Impact factor: 2.279

Review 2.  Patient stakeholder engagement in research: A narrative review to describe foundational principles and best practice activities.

Authors:  James D Harrison; Andrew D Auerbach; Wendy Anderson; Maureen Fagan; Martha Carnie; Catherine Hanson; Jim Banta; Gina Symczak; Edmondo Robinson; Jeffrey Schnipper; Celene Wong; Rachel Weiss
Journal:  Health Expect       Date:  2019-02-13       Impact factor: 3.377

3.  Process evaluations of primary care interventions addressing chronic disease: a systematic review.

Authors:  Hueiming Liu; Alim Mohammed; Janani Shanthosh; Madeline News; Tracey-Lea Laba; Maree L Hackett; David Peiris; Stephen Jan
Journal:  BMJ Open       Date:  2019-08-06       Impact factor: 2.692

4.  Openness, inclusion and transparency in the practice of public involvement in research: A reflective exercise to develop best practice recommendations.

Authors:  Laura J E Brown; Tommy Dickinson; Stuart Smith; Christine Brown Wilson; Maria Horne; Kate Torkington; Paul Simpson
Journal:  Health Expect       Date:  2017-11-03       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.